RNS Number : 1734R

Abingdon Health PLC

25 October 2023

Abingdon Health plc

("Abingdon Health" or the "Company")

Director Dealing

York, U.K. 25 October 2023: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests announces that on the 24(th) October 2023, Dr Chris Hand, Non-Executive Chairman purchased ordinary shares of 0.025 pence each in the Company ("Ordinary Shares").

Further details are as follows:

 Director              No. Ordinary          Aggregate         Enlarged          Enlarged 
                   Shares Purchased     Purchase Price          Holding          Holding* 
                                            (Pence per    (No. Ordinary        (Per cent. 
                                       Ordinary Share)          Shares)          of Total 
                                                                           Voting Rights) 
 Dr Chris Hand              150,000             10.167       13,178,467            10.83% 

*Excluding options over Ordinary Shares

The Notification of Dealing Form required in accordance with UK MAR is set out below.


 Abingdon Health plc                                          www.abingdonhealth.com/investors/ 
 Chris Yates, Chief Executive Officer                                           Via Walbrook PR 
 Chris Hand, Non-Executive Chairman 
 Singer Capital Markets (Sole Broker                                   Tel: +44 (0)20 7496 3000 
  and Nominated Adviser) 
 Peter Steel, Alex Bond, Jalini Kalaravy 
 Walbrook PR Limited                        Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com 
 Paul McManus, Phillip Marriage,                         Mob: +44 (0)7980 541 893 / +44 (0)7867 
  Alice Woodings                                                                        984 082 
                                                                            +44 (0)7407 804 654 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

       Details of the person discharging managerial responsibilities 
  1     / person closely associated 
 a)    Name                            Dr Chris Hand 
      ------------------------------  -------------------------------------------- 
       Reason for the notification 
 a)    Position/status                 Non-Executive Chairman 
      ------------------------------  -------------------------------------------- 
 b)    Initial notification            Initial notification 
      ------------------------------  -------------------------------------------- 
       Details of the issuer, emission allowance market participant, 
  3     auction platform, auctioneer or auction monitor 
 a)    Name                            Abingdon Health plc 
      ------------------------------  -------------------------------------------- 
 b)    LEI                             213800XFI4WV3FBILO20 
      ------------------------------  -------------------------------------------- 
       Details of the transaction(s): section to be repeated 
  4     for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
 a)    Description of the              Ordinary Shares of 0.025 pence each 
        financial instrument, 
        type of instrument 
       Identification code             GB00BLF79J41 
 b)    Nature of the transaction       Purchase of Ordinary Shares 
      ------------------------------  -------------------------------------------- 
 c)    Price(s) and volume(s) 
                                            ---------------------  ----------- 
                                             Price(s)               Volume(s) 
                                            ---------------------  ----------- 
                                             10 pence per share     100,000 
     10.5 pence per 
      share                                                          50,000 
   --------------------------------------------------------------  ----------- 
 d)    Aggregated information 
  - Aggregated volume             150,000 
  - Price                         10.167 pence per share 
 e)    Date of the transaction         24(th) October 2023 
      ------------------------------  -------------------------------------------- 
 f)    Place of the transaction        London Stock Exchange, AIM 
      ------------------------------  -------------------------------------------- 

About Abingdon Health plc

Abingdon Health is a leading lateral flow contract research ("CRO") and contract development and manufacturing organisation ("CDMO") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from "idea to commercial success."

The Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes.

Abingdon Health's Abingdon Simply Test (TM) range of self-tests is an ecommerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test (TM) ecommerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland such as pharmacy chains.

Founded in 2008, Abingdon Health is headquartered in York, England.

For more information visit: www.abingdonhealth.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

October 25, 2023 02:00 ET (06:00 GMT)

Abingdon Health (LSE:ABDX)
Historical Stock Chart
From Jan 2024 to Feb 2024 Click Here for more Abingdon Health Charts.
Abingdon Health (LSE:ABDX)
Historical Stock Chart
From Feb 2023 to Feb 2024 Click Here for more Abingdon Health Charts.